Why is the Bubs share price under pressure on Monday?

Bubs has released its fourth-quarter update this morning.

| More on:
watching asx share price represented by investor looking up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price is starting the week in the red.

In morning trade, the infant formula company's shares were down as much as 5% to 19 cents.

Why is the Bubs share price falling?

Investors have been hitting the sell button today after the company reported a sizeable decline in revenue for the fourth quarter. Here's a summary of how Bubs performed for the three months ended 30 June:

  • Gross revenue down 59% to $20 million
  • Infant formula revenue down 52%
  • Operating expenses up 110%
  • Quarterly operating cash outflow of $13 million
  • FY 2023 revenue down 29% to $73.7 million
  • FY 2023 operating cash outflow of $46.6 million

What happened during the quarter?

For the three months, Bubs reported a 59% decline in revenue over the prior corresponding period to $20 million. This reflects a whopping 96% decline in China revenue to just $1.4 million, which comfortably offset a 97% increase in USA revenue.

Management advised that its China revenues have been impacted by excess stock in trade and the ongoing dispute with Willis and Alice. Full-year revenue came in at $13.6 million, which was down 75% from $53.6 million in FY 2022.

In Australia, the company's revenue was up 7% during the fourth quarter to $5.1 million. This led to full-year revenue in the home market growing 19% to $15.2 million in FY 2023.

Management notes that the US business continues to build momentum in all go-to-market channels. This led to a 97% increase in revenue to $11.8 million for the fourth quarter and a 95% increase in FY 2023 revenue to $23.8 million. The company also highlights that it is on track to meet all regulatory milestones for permanent access to the USA market.

Bubs' cash burn continued during the quarter, with the company continuing to spend more producing its infant formula than it receives from customers. This led to an operating cash outflow of $13 million for the quarter and $46.6 million for FY 2023. However, the company's new management team expects to reduce its monthly cash outflow by half by the second quarter of FY 2024.

At the end of the period, the company had cash of $26.1 million. Including unused finance facilities, its funding increases to $34 million.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

ResMed share price jumps 10% on strong quarterly update

ResMed has impressed the market with its third-quarter update.

Read more »

Delighted adult man, working on a company slogan, on his laptop.
Earnings Results

Bank of Queensland share price leaps 6% on improving outlook

ASX 200 investors are bidding up the Bank of Queensland share price on Wednesday.

Read more »

Photo of two women shopping.
Earnings Results

Premier Investments share price jumps 9% on results and demerger plans

The Smiggle and Peter Alexander owner has released its results. How did it perform?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Earnings Results

Soul Patts share price struggles on falling profits

ASX 200 investment house Soul Patts reported its half year results this morning.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Brickworks share price tumbles on disappointing half-year loss

This loss didn't stop the company from increasing its dividend again.

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
Earnings Results

ASX All Ords stock KMD tumbles as interim dividend cancelled

Investors are hitting the sell button on ASX All Ords stock KMD today.

Read more »

Coal miner holding a giant coal rock in his hand making a circle with his hand, symbolising a rising share price.
Energy Shares

New Hope share price charges higher despite profit crunch and huge dividend cut

Weaker coal prices have hit this miner's profits and dividend hard.

Read more »